American Capital Advisory »

Silverback Therapeutics shares owned by American Capital Advisory

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by American Capital Advisory from 13F filings

Historical chart of American Capital Advisory investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by American Capital Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by American Capital Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $136k 14k 10.05
2025-06-30 $234k 13k 17.45

More positions owned by American Capital Advisory

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Dimensional Etf Trust Us Equity Market (DFUS)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Invesco Actively Managed Exc Total Return (GTO)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Labcorp Holdings Com Shs (LH)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Philip Morris International (PM)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl C (GOOG)
State Street Corporation (STT)

View all positions for American Capital Advisory

Top funds holding Silverback Therapeutics

RA Capital Management
OrbiMed Advisors
Deerfield Management Company
BlackRock
Rubric Capital Management
Sr One Capital Management
Vanguard Group
Standard Life Aberdeen
State Street Corporation
Alliancebernstein
Franklin Resources
Citadel Advisors
Casdin Capital
Geode Capital Management
Southpoint Capital Advisors

View all funds holding Silverback Therapeutics